Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZOPROMAF: Ozone Therapy for MRONJ
NCT05036837Phase 2Suspended
- Sponsor
- University of Palermo
- Start
- Feb 2018
- Primary completion
- Mar 2020
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of medical ozonated water in medication-related osteonecrosis of the jaw (MRONJ), sponsored by University of Palermo. Started Feb 2018; status: suspended.
02
Drugs
medical ozonated water
03
Conditions
medication-related osteonecrosis of the jaw (MRONJ)
Beyond the preview
Go deeper on NCT05036837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05036837.